Pliva's Win In 5th Circ. Is A Blueprint To Beat 'Off-Label' Suits
The Fifth Circuit recently freed Pliva Inc. and other generic-drug makers from claims that their off-label promotion of a generic heartburn drug to treat morning sickness was "dangerous" and led to...To view the full article, register now.
Already a subscriber? Click here to view full article